CNS Sarcoidosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which CNS Sarcoidosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which CNS Sarcoidosis trials you may qualify forTo facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
What is this study about? This research is focused on improving the care for people with rare heart muscle diseases, known as rare cardiomyopathies. These are u…
The goal of this observational study is to create a single macro registry system with data collection on common clinical features, grouping the different rare d…
The AYLo study (AutoimmunitY and Loss of y - Investigating the Role of Hematopoietic Mutations and Mosaic Mutation in the Y Chromosome in Autoimmune Rheumatolog…
Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk fo…
The Swiss-Ped-IBrainD is a national patient registry that collects information on diagnosis, symptoms, treatment, and follow-up of pediatric patients with an in…
The purpose of this study is to see if treatment with H.P. Acthar® Gel will result in the improvement and long-term stabilization of clinical and radiographic a…
Phase II study to evaluate the clinical potential of 68GaNOTA-anti-MMR-VHH2 for in vivo imaging of Macrophage Mannose Receptor (MMR)-expressing Macrophages by m…
There is a need for a more reliable, expeditious therapy that can be used as an alternative to glucocorticoids in severe Central Nervous System (CNS) sarcoidosi…